Regional Interaction Between Myocardial Sympathetic Denervation, Contractile Dysfunction, and Fibrosis in Heart Failure with Preserved Ejection Fraction: C-hydroxyephedrine PET Study
Overview
Nuclear Medicine
Radiology
Authors
Affiliations
Purpose: This investigation aimed to identify significant predictors of regional sympathetic denervation quantified by C-hydroxyephedrine (HED) positron emission tomography (PET) in patients with heart failure with preserved left ventricular ejection fraction (HFpEF).
Methods: Included in the study were 34 patients (age 63 ± 15 years, 23 men) with HFpEF (left ventricular ejection fraction ≥40%) and 11 age-matched volunteers without heart failure. Cardiac magnetic resonance imaging was performed to measure left ventricular size and function, and the extent of myocardial late gadolinium enhancement (LGE). C-HED PET was performed to quantify myocardial sympathetic innervation that was expressed as a C-HED retention index (RI, %/min). To identify predictors of regional C-HED RI in HFpEF patients, we propose a multivariate mixed-effects model for repeated measures over segments with an unstructured covariance matrix.
Results: Global C-HED RI was significantly lower and more heterogeneous in HFpEF patients than in volunteers (P < 0.01 for all). Regional C-HED RI was correlated positively with systolic wall thickening (r = 0.42, P < 0.001) and negatively with the extent of LGE (r = -0.43, P < 0.001). Segments in HFpEF patients with a large extent of LGE had the lowest regional C-HED RI among all segments (P < 0.001 in post hoc tests). Multivariate analysis demonstrated that systolic wall thickening and the extent of LGE were significant predictors of regional C-HED RI in HFpEF patients (both P ≤ 0.001).
Conclusion: Regional sympathetic denervation was associated with contractile dysfunction and fibrotic burden in HFpEF patients, suggesting that regional sympathetic denervation may provide an integrated measure of myocardial damage in HFpEF.
The sympathetic nervous system in heart failure with preserved ejection fraction.
Chang J, Ramchandra R Heart Fail Rev. 2024; 30(1):209-218.
PMID: 39438394 PMC: 11646211. DOI: 10.1007/s10741-024-10456-0.
The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF.
Triposkiadis F, Briasoulis A, Sarafidis P, Magouliotis D, Athanasiou T, Paraskevaidis I J Clin Med. 2023; 12(20).
PMID: 37892623 PMC: 10607346. DOI: 10.3390/jcm12206486.
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application.
Tersalvi G, Beltrani V, Grubler M, Molteni A, Cristoforetti Y, Pedrazzini G J Cardiovasc Dev Dis. 2023; 10(5).
PMID: 37233187 PMC: 10218989. DOI: 10.3390/jcdd10050220.
Gatterer C, Wollenweber T, Pichler V, Vraka C, Sunder-Plassmann G, Lenz M J Nucl Cardiol. 2023; 30(5):1810-1821.
PMID: 36855009 PMC: 10558396. DOI: 10.1007/s12350-023-03205-7.
Nakajo M, Horizoe Y, Kawaji K, Jinguji M, Tani A, Fukukura Y Jpn J Radiol. 2022; 41(4):437-448.
PMID: 36441441 PMC: 10066163. DOI: 10.1007/s11604-022-01365-z.